Navigation Links
Early embryos can correct genetic abnormalities during development
Date:7/5/2011

gy, as mosaicism could not be ruled out with a biopsy of a single cell from each cell type at the blastocyst stage. Incredibly, a high proportion (64%) of embryos showed complete genetic correction in both the ICM and TE cell populations. In other embryos, either the ICM or TE, but not both, showed genetic correction. In still others, both the ICM and TE remained abnormal. Interestingly, in all samples, the type of abnormalities that were documented at day three were different to the abnormalities observed at the later, blastocyst stage."

Out of the 126 embryos, 62 (49.2%) were euploid and 64 (50.8%) were aneuploid at day three; of these 43 (69.4%) of the euploid embryos developed to the blastocyst stage, while only 25 (39.1%) of the aneuploid embryos did. Of the 25 aneuploid day-five embryos, 68% possessed a euploid ICM and 76% possessed a euploid TE, with 64% having both a euploid ICM and TE. Therefore, 16 of the 25 had correction in both the TE and ICM cells.

Prof Kearns said: "These results suggest that there is a dynamic process of genetic normalisation that occurs in the developing human embryo. It is likely that there is considerable cellular mosaicism in many cleavage stage embryos and that there are mechanisms in place that cause marginalisation of abnormal cells while allowing growth of normal cells. The exact mechanisms that allow this, however, at this time are still unknown. The existence of such a process has significant implications for furthering numerous scientific fields."

For fertility treatment, the discovery that a large percentage of embryos deemed to be abnormal at day three could become normal at day five suggests that during PGS, day five is the better time to predict the ultimate chromosomal status of the embryo, rather than day three. In addition, if a day-three embryo was found to be aneuploid, then these findings suggest that it would be worth waiting and testing the trophectoderm at day five before making the
'/>"/>

Contact: Hanna Hanssen
hanna@eshre.eu
32-047-335-3381
European Society of Human Reproduction and Embryology
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Early-season strawberry tested in high elevation conditions
2. Early light refines the brains circuitry for vision
3. Harvard scientists see the early cellular cause of dry eye disease for the first time
4. Women who start prenatal vitamins early are less likely to have children with autism
5. Targeted adalimumab treatment can optimize long-term outcomes for patients with early RA
6. JGIs Susannah Tringe receives prestigious $2.5M DOE Early Career Research Award
7. A tale of 2 lakes: One gives early warning signal for ecosystem collapse
8. Early cancer treatment successes lead to CAREER Award for Rafael Davalos
9. Protein adaptation shows that life on early earth lived in a hot, acidic environment
10. Public forum: Japan and early lessons for the nuclear industry
11. Pancreatic Cancer Action Network-AACR Pathway to Leadership Grants awarded to early-career investigators
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2015)... 2015   Epic Sciences , a precision diagnostics company ... Murali Prahalad , Ph.D., president and CEO, is scheduled ... (PMWC) 2015: Silicon Valley, which is taking place at the ... on January 26-28, 2015. Dr. Prahalad ... Biomarkers." Last year, Epic Sciences was a finalist in the ...
(Date:2/5/2015)... Research and Markets ( http://www.researchandmarkets.com/research/6lngtl/global_biometrics ... "Global Biometrics Market (2014-2020): Market Forecast By Technologies, ... to their offering. , In ... is anticipated to overtake North America ... spending towards IT security, government biometric based projects ...
(Date:1/22/2015)... , Jan. 13, 2015 /PRNewswire/ - Today, FindBiometrics, the leading ... the launch of its new website design. "When ... its infancy", says Peter O,Neill , founder and CEO ... the industry needs involvement from the key players on a ...
Breaking Biology News(10 mins):Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2
... on the way for millions of people on the East ... have reported a key advance in efforts to develop the ... major nuisance to homeowners and a devastating pest to some ... that infects a common weed and found that it shows ...
... at the 35th Congress of the European Society for Medical ... Italy, presented results that suggested it may be possible to ... to respond to subsequent lines of chemotherapy. Dr Bernardo,s ... metastatic breast cancer in their centre between 1992 and 2006. ...
... drug being developed as a treatment for ovarian cancer has ... patients in a Phase-II clinical trial, an international research group ... Institute in the USA reported the results of the single-agent ... the 35th Congress of the European Society for Medical Oncology ...
Cached Biology News:Progress toward first commercial repellent for East Coast's stinker 2Investigational ovarian cancer drug shows promise against platinum resistant disease 2
(Date:2/26/2015)... , Feb. 26, 2015  23andMe, the leading ... Kate Black as Privacy Officer and Corporate Counsel. ... state privacy laws as well as health care regulations. ... she will be responsible for reviewing, updating and enhancing ... the U.S. and abroad. She joined the company January ...
(Date:2/26/2015)... 2015 Protiviti ( www.protiviti.com ), a global ... Governance Portal , designed to increase the efficiency ... tasks across multiple business units and projects. The Governance ... better align their controls with the COSO ( Committee ... In response to client feedback, Protiviti has also included ...
(Date:2/26/2015)...  NuGene International, Inc. ("NuGene") (OTCQB: NUGN), the ... hair rejuvenation, has announced that it has selected ... investor relations and strategic communications. ... diversification strategies – and we need to communicate ... Ali Kharazmi CEO of NuGene when announcing this ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 Already well ... gauging line by expanding its Length Gauge offerings with ... gauges. , Specifically, HEIDENHAIN’s pencil probe-style SPECTO ... force specification. Two new 1Vpp, 12mm stroke length ... force applications. One is a variant with a weak ...
Breaking Biology Technology:23andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3NuGene International, Inc. Selects Capital Market Relations for Strategic Investor Relations 2NuGene International, Inc. Selects Capital Market Relations for Strategic Investor Relations 3Accuracy and Versatile Gauging Go Hand in Hand at HEIDENHAIN 2
... Zyvex Labs today announced,its first company spinout: ... Rob,Burgess, PhD, former Vice President of Research & ... Group Leader of Life Sciences,at Zyvex Corporation. ... in Life,Sciences. The company seeks to apply nanoparticle ...
... The law firm of Finkelstein,Thompson LLP announces that ... States District Court for the Southern District of New ... stock of GPC Biotech AG,("GPC Biotech" or the "Company") ... 24, 2007, inclusive (the "Class Period"). Finkelstein Thompson LLP,is ...
... MINNEAPOLIS, Aug. 21 Vital Images, ... of enterprise-wide advanced,visualization and analysis solutions, today ... advanced visualization and analysis product,solutions with the ... This,comprehensive package offers powerful advanced visualization and ...
Cached Biology Technology:NanoMed, Inc. Spins Out of Zyvex Labs 2Finkelstein Thompson LLP Announces GPC Biotech AG Investigation 2Vital Images Releases Next Generation Enterprise-Wide Solutions Featuring Vitrea(R) 4.0 and ViTALConnect(R) 4.1 2Vital Images Releases Next Generation Enterprise-Wide Solutions Featuring Vitrea(R) 4.0 and ViTALConnect(R) 4.1 3Vital Images Releases Next Generation Enterprise-Wide Solutions Featuring Vitrea(R) 4.0 and ViTALConnect(R) 4.1 4
... cells were cultured in Ham's F12K medium with ... phase of growth. In order to keep the ... in acetone-methanol. The cells are arrayed on a ... wells surface specifically treated to enhance cellular attachment ...
Mouse polyclonal antibody to REXO4 - XPMC2 prevents mitotic catastrophe 2 homolog (Xenopus laevis)...
... Plus Microsphere/Microarray Stabilizer is an aqueous solution ... other non-toxic chemicals in a PBS buffer ... This product contains a combination of ... preservative. StabilCoat Plus Stabilizer provides optimum ...
... The mini incubation trays ... used to screen antigens that ... membrane. Each tray has eight ... channels that accommodate strips cut ...
Biology Products: